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Abstract The developmentofthehigh-resolution computed tomography (HRCT) has improved the ability to detect
and quantify emphysema in various groups of patientswith chronic airflow obstruction (COPD). Significant correlations
havepreviouslybeenfoundbetweenindicesof air flowobstruction, hyperinflation, reduceddiffusingcapacity forcarbon
monoxide (DLCO), and the extent of emphysema (emph.%) assessed by HRCT. However, the relationship between
emph.% and ventilation--perfusion (VA/Q) inequality in COPD is unknown.Twenty COPD patients with a mean forced
expiratory volume in1s (FEV1) of 38.2 (715.5)% inpercentof predictedvalue (%P), amean PaO2 value of 9.6 (71.3) kPa,
and a mean diffusing capacity of 43.6 (723.0)%P, were subjected tomeasurements by themultiple elimination inert gas
technique (MIGET).The extent of emphysema was determined by HRCTat both full inspiration, emph.I(%) and at full
expiration, emph.E(%), with a cut-off limitof910 Hounsfield Units (HU) using the‘‘Density Mask’’method.Theventila-
tion directed towards high VA/Q areas was 7.3 (710.2)% and the mean ventilation (V-mean) was elevated about three
times compared to normal.Themeanemph.(I)% andemph.(E) was 45.6 (716.9) and 32.7 (719.0)%, respectively. Signifi-
cantcorrelationswere shownbetweenthe emphysema extent and severallung functionparameters, butno correlation
was foundbetweenthe emphysema extent and theVA/Q relationships or the bloodgas values.Reduced DLCO%Pcorre-
latedwith less highVA/Q ventilation (r=0.73, Po0.05) for the subgroup of COPD patientswith DLCO(%P) less than 50%
(n=12).Conclusions: In COPD patients, suffering frommoderate to severe emphysemawithout severe blood gas impair-
ment, no correlationwas shown between the extent of emphysema, as assessed by HRCT, and the severity of ventila-
tion--perfusion inequality. A substantial collateral ventilation in severe emphysemamay be a mechanismthat prevents a
deterioration inVA/Q relationships and in bloodgas levels.r2002 Publishedby Elsevier Science Ltd
Available online athttp://www.sciencedirect.com
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Di¡erent patterns of ventilation^perfusion (VA/Q) mis-
match invarious groups of patientswith chronic obstruc-
tive pulmonary disease (COPD) have previously been
described by Wagner et al. (1). COPD patients with re-
duced elastic recoil, marked hyperin£ation and a mini-
mum of sputum production have shown substantial
ventilation of poorly perfused lung regions (high VA/Q
areas) (1).Using xenon gas tracers, measuring the reten-
tion of inhaled and infused radioactive xenon gas, it hasReceived13 November 2001; accepted in revised form18 March 2002
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reduced alveolar blood £ow in relation to lung volumes
(2).Compression and destruction of capillaries in the al-
veolar walls give rise to reduced alveolar blood £ow in
emphysema (3,4). Another group of COPD patientswith
cough and daily sputum production shows a substantial
perfusion of low VA/Q regions, probably as a result of re-
duced ventilation, re£ecting the mechanical airway ob-
struction and distortion of the small airways (1,2). By
the use of the xenon tracer method, it has previously
been shown that these bronchitic COPD patients have
normal or even increasedperipheralperfusion in relation
to their lung volumes (2).Thus, notonly lung functionbut
also alveolar perfusion and ventilation^perfusion ratios
are a¡ected by emphysema.However, in COPD patients
with severe airway obstruction and with an increase in
VA/Q inequality, insu⁄cient equilibration of gas tracers
TABLE 1. Anthropometric data, spirometric values and
extentof emphysema (n=20)
Age (years) 60+8 Mean 7SD
EVF (%) 45.0 73.6
BMI (kg/m2) 23.6 74.8
FEV1 (%P) 38.2 715.5
FVC (%P) 74.2 717.3
RV (%P) 213.6 747.0
FRC (%P) 160.1 735.3
TLC (%P) 121.9 717.3
MEF (%P) 12.2 7 8.3
PaO2 (kPa) 9.6 71.3
PaCO2 (kPa) 5.1 70.7
DLCO (%P) 43.6 723.0
Meanpulmonarydensity (HU) 876.1 728.5
Emph. (I) % 45.6 716.9
Emph. (E)% 32.7 719.0
BMI, bodymass index; FEV1, forced expiratory volume
in1second;FVC, forcedvital capacity;FRC, functional re-
sidual capacity; MEF, mean expiratory £ow at 50% of
FVC;RV, residual volume;TLC, total lung capacity;DLCO,
di¡usioncapacity forcarbonmonoxide;EVF, erythrocyte
volume fraction; (%P), in percentage of predicted; Emph.
(I)%, extentof emphysema inpercentage oftotal pulmon-
ary parenchyma at full inspiration; Emph. (E)%, extent of
emphysema in percentage of total pulmonary parenchy-
ma at full expiration and HU,Houns¢eld Units.
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to themost severely a¡ected lung regions (5).
The multiple inert gas elimination technique (MIGET)
has formore than 25 years beenused to analyse theVA/Q
relationships in COPD (1).Using MIGET, it is possible to
accurately re£ect these relationships (at a di¡erence
from the xenon tracer method), at least during resting
conditions even in severeCOPD, irrespective ofwhether
the patients are in a stable condition or if acute respira-
tory insu⁄ciency has developed (6,7).
Mild emphysema is oftendi⁄cult to be detectedby or-
dinary chestradiograph images (8).The developmentof a
high-resolution computed tomography (HRCT) techni-
que has signi¢cantly improved the possibility of studying
the extent and localisation of emphysema in a non-inva-
sive way (8,9). It has previously been shown that the
‘‘Density Mask’’ technique (10) is a reliable method to
quantify the extent of emphysema.Microscopic ¢ndings
from post-mortem samples and resected lung tissues
fromCOPDpatients have shown that a reduced alveolar
wall volume/unit lung volume correlates signi¢cantly
with mean lung density and to areas of low attenuation
shown by computed tomography (CT) (11). The extent
of emphysema determinedby CT in emphysemapatients
with varying degrees of air£ow obstruction, has been
shown to correlate signi¢cantly with lung function tests
such as forced residual capacity (FRC), forced expiratory
volume in one second (FEV1), residual volume (RV) and
di¡using capacity for carbon monoxide (DLCO) (9,12^14).
However, it is notknownwhether the extentor severity
of emphysema assessedbyHRCTmeasurements also re-
lates to the severity of ventilation^perfusion inequality.
Therefore, we correlated the extent of emphysema as-
sessed by HRCTwith ventilation^perfusion ratios mea-
sured by the multiple inert gas technique in 20 stable
COPD patients (with di¡erent levels of airway obstruc-
tion). The extent of emphysema assessed by HRCT and
VA/Q ratios was then related to spirometry parameters
and to the di¡using capacity of carbonmonoxide.
PATIENTS
Twenty patients (10 smokers and 10 ex-smokers), eight
men and 12 women, with a mean duration of COPD of
10 (78) years and a mean age of 60 (78) years were in-
cluded in our study. Two subjects had homozygotic a-1-
antitrypsin de¢ciency.None of the patients had a history
of atopy or asthma and all su¡ered from irreversible air-
way obstruction as shown by the FEV1valuewhich chan-
ged less than10% from the baseline value15min after the
inhalation of 2.5mg nebulised salbutamol. No patient
had any other lung disease, other than COPD, and they
had all been free from cardio-pulmonary exacerbations
for at least 1 month before being included in the study.
The patients were selected by consecutive screeningwhenvisitingour outpatientclinic.They all received their
ordinary medication unchanged for at least 2 months
prior to the measurements. Spirometric values re-
mained unchanged for 2 months after theVA/Q tests had
been performed, con¢rming that the patients were in
stable condition. Arterial oxygen tension (PaO2) was
above 8.0 kPa in all the subjects (Table1).
Seventeen patients used b2-inhalers, 10 patients in-
haled corticosteroids and four patients used oral diure-
tics because of mild chronic right-sided heart failure.
This study was approvedby the Ethical Committee of
Huddinge University Hospital and all subjects gave their
informed consent.
METHODS
Measurement of ventilation^perfusion
(VA/Q) ratios
Ventilation^perfusion ratios were measured using the
multiple inert gas elimination technique (15,16). A modi-
¢ed method was used in which six mixed expired inert
gas levels weremeasured, while arterial levels were esti-
mated from samples of peripheral venous blood taken
936 RESPIRATORYMEDICINE90min after the commencement of infusion of the inert
gases (17,18).
The inertgas sampleswere analysedbygas chromato-
graphy (Varian 3300,Varian Associates Inc.,CA,U.S.A.).
Retention and excretion ratios were computed and the
solubility of each inert gaswas determinedby a two-step
procedure, enabling the estimation of theVA/Q distribu-
tion.Meanvalues from three runswere used to achieve a
low standard error (18).Oxygen uptake (VO2) and CO2
productionweremeasuredby analysing the O2 and CO2
content from aDouglas bag at the same time as the inert
gas sampling was carried out (Ametek, Pittsburgh, PA,
U.S.A.). Minute ventilation was measured by analysing
the volume of the contents of the Douglas bag.
ThemeanVA/Q ratios for ventilation andperfusiondis-
tributions are expressedbyV-mean andQ-mean, respec-
tively. From the VA/Q distributions, data were derived
regarding shunt (perfusion of lung regions withVA/Q ra-
tioso0.005); ‘‘lowVA/Q ’’ levels (perfusion of lung regions
with 0.005oVA/Qo0.1); ‘‘high VA/Q’’ levels (ventilation of
lung regions with 10oVA/Qo100) and dead space (venti-
lation of lung regions withVA/Q ratios4100).
Cardiac output (CO) (l/min) was assumed to be1/50 of
theVO2 (ml/min) (VO2 method). Analysis from two stu-
dies in our laboratory (19,20) concerning stable, resting
patients with severe COPD and moderate hypoxaemia,
showed that the CO estimates by theVO2 method, per-
formedduringrightheartcatheterisation,was not signif-
icantly di¡erent from CO assessments using the
thermodilution method and that these two methods
correlated signi¢cantly (r=0.72,P=0.001). In patientswith
severe cystic ¢brosis, we have previously shown that
changes in CO of 50% are required to signi¢cantly in£u-
ence CO-derived parameters, such as shunting (21).On
the basis of these studies, we concluded that the CO es-
timates (assessedbyVO2) andvariables derived fromCO
such as shunting and low VA/Q, in stable, resting COPD
patients without severe hypoxaemia, like in the present
study, should be accurate enough to result in valid corre-
lations betweenCO-derivedparameters and other vari-
ables.
The dispersion of ventilation and perfusion for di¡er-
ent VA/Q ratios is expressed as a logarithmic standard
deviation of the ventilation distribution (log SDV) and of
the perfusion distribution (log SDQ).Thus, the degree of
overall ventilation^perfusion mismatch is expressed by
log SDVand log SDQ.When the peripheral venous sam-
pling technique is used, log SDVand log SDQ are under-
estimated by about 6% (18) and the upper normal limits
regarding log SDVand log SDQ are 0.75 and 0.70, respec-
tively (22).Theoreticalwork has shown that VA/Q disper-
sion indices are in£uenced only to a minor degree by
estimates of CO (17).Mean values from three runs were
used to achieve a low standard error of themethod (18).
The ¢t of the derived VA/Q distributions to themeasured
data, expressed as the remaining sum of squares (RSS)should not exceed 6.0 inmore than 50% of themeasure-
ments (15,18).The mean RSS from all data in the present
study was1.6 (71.8).
Blood gas analyses
Blood gas analyses were performed on radial arterial
samples (ABL 520, Radiometer, Copenhagen, Denmark)
immediately after VA/Q measurements, while breathing
air, as the patients were sitting in a semi-recumbent po-
sition.
Spirometry tests
Static anddynamic spirometry wereperformedwith the
patient in a sitting position. To avoid the in£uence of
forcedexpiration on secretion and therebygas exchange,
the spirometry measurements were always performed
after the conclusion of the gas exchange study.The FEV1
(the best value of threewas accepted), forced vital capa-
city (FVC), vital capacity (VC) andmean expiratory £ow
at 50% of FVC (MEF 50%) were measured by dynamic
spirometry. The functional residual capacity (FRC) was
determined by body plethysmography. The residual vo-
lume (RV) and the total lung capacity (TLC) were then
calculated from the FRCvalue.
Dynamic spirometry and lung volume measurements
were carriedoutwith a Pulmonary Function Laboratory
2400 and 6200, respectively (Sensor Medics BV, Biltho-
ven, The Netherlands). The values from the spirometry
tests are presented as percentage of predicted (%P).
The normal values were selected from equations of the
European Community for Coal and Steel (23).
Di¡using capacity for carbon monoxide (DLCO) was
measured by the single breath method (24). The mean
value of two technically acceptable measurements was
used. None of the patients had anaemia or polycythae-
mia and consequently no correction for the Hb-level
was needed.
High-resolution computed tomography
(HRCT)
CT scanning was performed in the supine position by a
Philips Tomoscan SR 7000 equipment (Philips Medical
System). The HRCT technique (1.5mm collimation, a
scanning time of 2.0 s, 140kV and150mA) was used and
the images were acquired from the apices to the dia-
phragm at 2 cm intervals. Resting time before CT-scan-
ning was performed was at least 2minutes and the
duration for the whole investigation was 10min. In each
patient, 11^15 layers were scanned at inspiration toTLC
and at expiration to RV.The mean normal density (elec-
tronic density of the lung parenchyma relative to water)
in healthy lungsmeasuredbyCTexpressed in Houns¢eld
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746 (742)HU formen (25).
Emphysema extent
To quantify the extentof emphysema the‘‘DensityMask’’
programme of the CT-scanner was used without con-
trast medium (10).With a track-ball our radiologist (HR)
outlined the lungparenchyma excluding solidbone struc-
ture, hilum, mediastinum, air in the trachea and in the
main bronchi. In each HRCT-section, the scanner mea-
sured the area of pixels (r0.5mm2) with attenuation va-
lues between 400 HU and 1000 HU, corresponding
to lung tissue (26). Areas with density levels between
910 HU and 1000HU were considered emphysema-
tous (27^29).
The density of the total pulmonary tissue at full end
inspirationwas automatically calculated by the scanner’s
computer program assessed as the mean value of at-
tenuation (expressed in HU). This was performed at
three di¡erent levels; at the top of the aortic arch, at
the origin of the right lower lobe bronchus, and at 3 cm
above the top of the diaphragm (13). At each of these le-
vels, the ratio of lung areas with low attenuation
(o910HU) to total lung area (400 HU to
1000HU) was expressed as the percentage of emphy-
sema (emph.%) andwas calculatedboth at full inspiration
denominated emph.(I)% and at full expiration denomi-
natedemph.(E)%.The cut-o¡ points for separating di¡er-
ent groups of emph.(E)% were modi¢ed from previous
studies (29,30).
Our radiologistwho examined theHRCTscans hadno
knowledge of the results from theventilation^perfusion
ratio measurements or from the pulmonary function
tests.
Statistical analysis
The data are presented as a mean7SD Correlations be-
tween blood gases and lung function tests was deter-
mined by linear regression. Only non-parametric
statisticalmethodwasused since the extentof emphyse-
ma and VA/Q ratios did not show a normal distribution.
Correlations between variables were assessed by the
Spearman rank test and di¡erences between groups
were examined using the Mann^Whitney U-test. Re-
garding the di¡erences between the three groups, the
Kruskal^Wallis test was used.The importance of di¡er-
entvariables for thevariabilityof a dependentparameter
was assessed by stepwise regression.
RESULTS
The chest radiograph images showedhyperin£ation in all
patients.HRCTshowed areaswith low attenuation levelsscattered around the entire lung. No images showed
paraseptal or subpleural localised air cysts or ‘‘bullous’’
patterns.The automatically calculatedvalues for the lung
density and the extent of emphysema are shown inTable
1. The mean lung density level was 876.1 (728.5)HU,
which is lower than normal (722 HU7 44 forwomen
and746HU742 formen) (25).Emph.(I)% for the entire
group was 45.6 (716.9)% and emph.(E)% was
32.7(719.0)%.
Due to technical reasons, measurements of themean
lungdensity levelwereperformedin only13 patients. Sig-
ni¢cant di¡erences between these13 patients compared
to the remaining seven patientswere only theirmean le-
vels of TLC and FRC (Po0.05, respectively).
Two patients had mild airway obstruction [FEV1 60^
70(%P)], seven had moderate [FEV1 40^59(%P)], and 11
had severe airway obstruction [FEV1o40(%P)] (Table 1).
All patients su¡ered from severe hyperin£ation [RV%Pof
213.6 (747.0)%] and a reduced di¡using capacity
[DLCO(%P) of 43.6 (723.0)%] compared to normal
(23,24). They were all eucapnic with a mean PaCO2 of
5.1 (70.7) kPa and a mean PaO2 close to normal of 9.6
(71.3) kPa (Table1).
HighVA/Q value dominated the ventilation^perfusion
inequality pattern. About 7% of the ventilation was di-
rected towards highVA/Q areas (normal valueo1%) yield-
ing an increase in the V-mean level to 2.9 (71.6)
compared to the level of healthy individuals (0.7^1.2) (Ta-
ble 2).The dispersion of ventilation, log SDV, was also in-
creased compared to normal (normal valuer0.75) (22),
to ameanvalue of 0.95 (70.43) and the dispersion ofper-
fusion, log SDQ, was at the upper normal limit of 0.68
(70.20) (normal value r0.70) (22). About 2% of CO
was directed to shunt areas and almost no perfusion
was directed towards low VA/Q areas (Table 2).
Correlations between lung function and
HRCT
Close inverse correlations were found between
emph.(E)% and FEV1(%P) (Fig. 1) as well as to other in-
dices of air£ow obstruction such as FVC(%P), FEV1/
VC(%) and MEF 50%(%P) (Table 3). A strong inverse cor-
relationwas also shown between emph.(E)% and the dif-
fusing capacity (Fig. 2). Emph.(E)% was positively
correlated with indices of hyperin£ation such as RV(%P)
(Table 3). However, in three patients with rather severe
airway obstruction [a median FEV1(%P) of 53 (49^56)%
and a median RV(%P) of 165 (153^207)%] a median
emph.(E)% of only 5.5 (3.6^11.4)% was shown by HRCT.
By stepwise regression analysis for all our COPD pa-
tients, we noted that 69% of the variability in emph.(E)%
was explained by FEV1/VC(%P) and a further 8% by
DLCO(%P).The parameters FEV1(%P), RV(%P), FRC(%P),
MEF50%(%P), Q-mean and V-mean however, failed to
TABLE 2. Ventilation-perfusionrelationships (n=20)
COPD patients Healthyindividuals
Mean 7SD Mean 7SD
V-mean 2.9 7 1.6 0.9 70.2
Q-mean 1.3 7 0.4 0.7 7 0.1
Log SDV 0.95 7 0.43 r0.75 F
Log SDQ 0.68 7 0.20 r0.70 F
Shunt 1.9 7 1.4 0.08 70.15
Low VA/Q 0.1 7 0.4 0 0
HighVA/Q 7.3 710.2 0 0
Dead space 30.0 7 7.7 39.4 75.6
VE (l/min) 10.2 7 2.5
Thenormalvaluesregardinglog SDVandlog SDQare adopted fromreference (22) andthe othernormalvalues are adopted
from reference (30).V-mean,The mean VA/Q ratio for ventilation; Q-mean,The mean VA/Q ratio for perfusion; log SDV,The
dispersion of ventilation; log SDQ,The dispersion of perfusion; shunt,VA/Qo0.005 in per cent of cardiac output; low VA/Q,
0.005oVA/Qo0.1 in per cent of cardiac output; high VA/Q, 10oVA/Qo100 in per cent of minute ventilation; dead space, VA/
Q4100 inpercentofminute ventilation and VE,Minute ventilation
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FIG. 1. Spearmanrankcorrelationsbetweenthe extentof em-
physema atfullexpirationemph.(E) (%) as shownbyHRCTscans
and forced expired volume in one second (FeV1) (%P) in 20
COPD patients, (r=0.83, Po0.001).
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beit slightly weaker correlations were found between
emph.(1)% and indices of air£ow obstruction, hyperin£a-
tion and DLCO%P (Table 3). No correlations were found
between blood gas levels and emph.(E)%. For technical
reasons, the mean lung density value at full inspiration
[emph.(I)%] was measured in only 13 of our COPD pa-
tients. The emph.(I)% for these patients was shown to
be inversely and signi¢cantly correlated with emph.(E)%
(r=0.70,Po0.05)without any correlation to the air£ow
obstruction, hyperin£ation, VA/Q inequality or low
DLCO%P (Table 3). However, signi¢cant correlations
were found between emph.(E)% and spirometry para-
meters for the13 patients inwhom themean lungdensity
was measured as for our entire patient group (data not
shown).Correlations between lung function, blood
gas exchange, ventilation^perfusion ratios
and extent of emphysema
No signi¢cant correlations were found between air-
£ow obstruction (measured by spirometry) and venti-
lation^perfusion inequality or between blood gas
values and VA/Q ratios. No signi¢cant correlations be-
tween reduced DLCO(%P) and any VA/Q parameter
(such as high VA/Q ventilation and elevated V-mean)
were found.
For the entirepatientpopulation, no signi¢cant corre-
lations were found between di¡erent VA/Q ratios or
blood gas levels vs emph.(I)% or vs emph.(E)%.However,
the di¡erence in emph.% at full inspiration and at full ex-
piration deceased with increasing emphysema extent
(r=0.47, Po0.05) (Fig. 3).
A reduced BMI correlated with emph.(E)% (r=0.53,
Po0.05). The PaO2 level related signi¢cantly to the
DLCO(%P) level (r=0.73,Po0.001) aswell as to theminute
ventilation (r=0.48, Po0.05).The PaCO2 level was inver-
sely correlated to FEV1(%P), DLCO(%P) and VC(%P)
(r=0.56 to0.67, Po0.01for all).
Subgroup analyses
Comparisons between groups consisting of ¢ve pa-
tients with emph.(E)% of r16% (trivial emphysema),
ten patients with emph.(E)% of 17^50 % (moderate em-
physema) and ¢ve patients with emph.(E)% of 450%
(severe emphysema) (29,31) (Table 4) concerning spiro-
metric values, VA/Q ratios and emph.(%) showed that
patients with moderate or severe emphysema had a
signi¢cantly more pronounced air£ow obstruction and
TABLE 3. Correlations between the extent of emphysema at full inspiration in percentage of healthy pulmonary parenchyma
[Emph.(I)%] and at full expiration inpercentage of healthypulmonaryparenchyma [Emph.(E)%] andmeanlungdensity atthree
levels assessedby HRCTvs spirometric values and VA/Q relationships
Emph. (I)% (n=20) Emph. (E)% (n=20) Meandensity (n=13)
r-Value P-Value r-Value P-Value r-Value P-Value
FEV1/VC (%) 0.76** 0.87*** 0.54 NS
FEV1 (%P) 0.69** 0.81*** 0.38 NS
FRC (%P) 0.69** 0.70** 0.37 NS
RV (%P) 0.71*** 0.77*** 0.36 NS
TLC (%P) 0.57** 0.57** 0.35 NS
MEF 50% (%P) 0.57* 0.78** 0.28 NS
DLCO (%P) 0.60** 0.73** 0.41 NS
HighVA/Q (%) 0.14 NS 0.15 NS 0.13 NS
V-mean (%) 0.25 NS 0.22 NS 0.49 NS
*Po0.05, **Po0.01, ***Po0.001regarding signi¢cantcorrelations.
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FIG. 2. Spearman rank correlations between the extent em-
physema at full expiration emph.(E) %, as shownby HRCTscans
and the di¡using capacity for carbon monoxide (DLCO) (%P) in
20 COPD patients, (r=0.71, Po0.01).
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FIG. 3. Spearmanrankcorrelationbetweenthe extentof em-
physema as shown by HRCTscans at full inspiration; (upper line)
and at full expiration (lower line) emph.(I) (%) and at full expira-
tion; emph.(E) (%) in 20 COPD patients, (r=0.94, P=0.001).
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group. Air£ow obstruction and hyperin£ation were
also signi¢cantly more pronounced in patients with se-
vere emphysema as compared with patients with mod-
erate emphysema. There was a signi¢cantly lower
DLCO(%P) value in patients with moderate or severe
emphysema compared with the patients in the trivial
emphysema group, but there was no signi¢cant di¡er-
ence with regard to DLCO(%P) value between patients
with moderate or severe emphysema. All these di¡er-
ences were con¢rmed by the Kruskal^Wallis test
(Po00.1 for emph.(E)% and for the other variables
the P-values varied between 0.01 and 0.05).
Ventilation towards high VA/Q areas was signi¢cantly
increased in the subgroup with moderate emphysema
compared with the trivial emphysema subgroup. In line
with this result there was a trend for an increased
ventilation distribution (log SDV) including an insigni¢-
cantly increased shunting in the moderate emphysema
subgroup compared with the trivial emphysema sub-
group. The mean VA/Q ratio for ventilation (V-mean)
was signi¢cantly increased compared with normal va-
lues for all subgroups (Table 2) and there were trends
towards an increased ventilation of high VA/Q areas and
for perfusion of shunting areas in patients with severe
emphysema compared with the trivial emphysema sub-
group.
However, for the 15 patients with an emph.(%E) of
416% no correlation was found between the increasing
extent of emphysema and VA/Q inequality.
In13 COPD patients, with a di¡using capacity for car-
bon monoxide ofo50%P,V-mean and highVA/Q ventila-
tion tended to correlate with an increase in DLCO(%P)
level, but if one patient with DLCO(%P) 445% was ex-
cluded, these correlations were no longer signi¢cant
(Figs. 4(a) and (b)).
TABLE 4. Di¡erences with regard to spirometric values and VA/Q relationships in COPD patients with di¡erent extent of
emphysema as assessed by HRCT
Emph. extentr16% (n=5) Emph. extent17^50% (n=10) Emph. extent>50% (n=5)
Mean7SD Mean7SD Mean7SD
FEV1/VC (%) 72.077.8 45.777.5** 36.077.3**
w
FEV1 (%P) 57.477.1 34.3712.7** 26.678.1**
FRC (%P) 121.8718.1 164.1733.7** 186.2713.3**
RV (%P) 159.6735.1 217.9733.9** 258.8720.9**w
TLC (%P) 107.079.5 123.8713.9* 139.479.4**w
DLCO (%P) 67.0728.4 39.4714.8* 28.4714.1*
Log SDV 0.7170.25 1.0370.37 NS 1.0370.65 NS
Log SDQ 0.6070.05 0.7170.21 NS 0.7070.29 NS
HighVA/Q (%) 1.172.5 8.979.7* 10.5714.2 NS
V-mean (%) 2.170.4 2.871.1 NS 3.972.6*
Q-mean (%) 1.470.1 1.270.3 NS 1.470.5 NS
VE (L/min) 9.373.1 10.472.2 NS 10.772.9 NS
Three levels:Emph. (I) % 28712 44711* 6774**
Emph. (E)% 1076 3179** 5974**z
*Po0.05, **Po0.01regarding signi¢cantdi¡erences between COPD patientswith extentof emphysema416% and COPD
patientswith extentof emphysemar16%.
wPo0.05, zPo0.01regarding signi¢cant di¡erences between COPD patients with extent of emphysema >50% and COPD pa-
tientswith extentof emphysema17^50%.
Emph. (I)%,Extentof emphysema at full inspiration inpercentage of healthypulmonaryparenchyma.
Emph. (E)%,Extentof emphysema at full expiration inpercentage of healthypulmonaryparenchyma.
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FIG. 4a. Spearman rank correlations between mean of VA/Q ratios for ventilation (V-mean) and the di¡using capacity for carbon
monoxide (DLCO) (%P) in13 COPD patientswith DLCO (%P)o50%, (r=0.57,Po0.05).4b Spearmanrankcorrelationsbetween venti-
lationof lungregionswith10oVA/Qo100, (highVA/Q) anddi¡usingcapacity forcarbonmonoxidein13COPDpatients,withDLCO (%P)
o50%, (r=0.57, Po0.05).
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Assessment of emphysema by theHRCT
method
HRCT may detect emphysematous areas which may be
as small as 0.5 cm2 (32).The ‘‘Density Mask’’ method has
the advantage of being less prone to observer bias com-
pared to visual scorings, since the outlined regions of in-
terest automatically denote the lung areas which arebelow the prede¢ned threshold of attenuation (33).
However, in healthy individuals and to a lesser extent in
emphysematous patients, lung areas of low attenuation
level may appear towards the end of the inspiratory
manoeuvre to TLC due to hyperin£ation (13,14,29). The
low attenuation areas may also appear as a result of ob-
struction of central or peripheral airways in patients
with chronic air£ow limitation, giving rise to air trapping
and ¢xed hyperin£ation (13,14). Furthermore, these low
VENTILATION^PERFUSION INEQUALITY 941attenuation areas may appear due to the existence of
truly emphysematous areas (13,14). In our study, as in pre-
vious studies (13,14,34), the di¡erences in the size of areas
with low attenuation shown by HRCT, between end in-
spiration and the end expiration diminished in patients
with more widespread emphysema during end expira-
tion.This corroborates the notion that less air is trans-
ported to and from the lungs as emphysema develops
(13,14).
Previous studies have shown that a cut-o¡ limit of
900 or 910HU, has been found to separate normal
from emphysematous lung tissue at full inspiration on
CT or HRCT (10,27,28). Recent research, however, im-
plies that a cut-o¡ limit of 950HU used on CT scans,
taken at full inspiration, de¢nes an evenmore exact limit
between hyperin£ated healthy and emphysematous pul-
monary tissue (33). It has alsobeennotedpreviously that
similar correlations between the severity of emphysema
and spirometry tests are found regardless if the cut-o¡
limit is set to910 or950HU (35).The riskof including
pulmonary areas with low attenuation level due to hy-
perin£ation instead of emphysema is reduced if the CT
scans are obtained at full expiration (13,14,27,31) and by
this mechanism the in£uence of the supine posture was
probablyminimised.By theuse of standardised coaching,
as in our study, the images can be obtained at reproduci-
ble levels of expiration (31,34).The extent of emphysema
assessed at full expiration by the ‘‘Density Mask’’ techni-
que has previously been shown to be one of themost ac-
curatemethods to distinguish patients with no or trivial
emphysema from those with moderate and severe em-
physema (13,29,30).We therefore chose to assess the ex-
tent of emphysema in our patients [emph.(E)%] with a
cut-o¡ limit for normal extent of low attenuation areas
ofr16% (13,27,31). Furthermore, in agreement with ear-
lier studies (13), we found that HRCT scans from three
levels correlate closely with images assessed at10^15 le-
vels. Statistical analysis was therefore performed using
average values of HRCT scans from only three levels
(seemethods).
Correlations between lung function and
HRCT
In the present investigation, as in previous studies, highly
signi¢cant correlations were found between indices of
air£owobstruction, hyperin£ation and the extentof em-
physema (13,27,29,31,34,35). In agreement with previous
results, somewhatmore signi¢cantcorrelationswere re-
corded between lung function tests and emph.(E)% as
comparedwith emph.(I)% (13,27,29,31,34,35).
The inverse correlationbetween the extentof emphy-
sema and FEV1 is primarily dependent on the reduced
elastic recoil inherent to emphysema (36). In disagree-
ment with previous reports (8,13,31), indices of air£owobstruction seemed to be of greater importance for
the variability in extent of emphysema than the
DLCO(%P) level. A reduction in the di¡usion capacity in
COPD may depend on parenchymal and capillary tissue
destruction due to the development of emphysema (3,8),
which in turn reduces the surface area available for gas
exchange. Furthermore, DLCO may be diminished due
to small airwaydisease (37,38)which decreases the in£ux
of air into the alveoli and thereby the alveolar ventilation
and thegas exchangebecomesreduced. Small airwaydis-
easemay have contributed to the ¢nding that four of our
patients had DLCO(%P) below 30% and an emph.(E)% of
only 30^45% (Fig. 2).
In disagreement with several other investigations
(27,31,34), mean lung density did not correlate to any in-
dex of lung function or gas exchange impairment in the
present study.The mean lung density measures the pro-
portions of air and liquid in both normal and emphyse-
matous parts of the lung which may explain why this
parameter is less sensitive to lung function impairments
compared tomeasurements of the extentof emphysema
(27). By measuring the extent of emphysema by HRCT,
only the diseased parts of the lung parenchyma are high-
lighted. Furthermore, in several earlier studies, a wide
range of subjects were included, ranging from patients
with rather trivial emphysema and normal lung function
to patients with large emphysematous areas with se-
verely reduced lung function (27,31,34). Our patients
comprised an rather homogenous group, since 80% of
our subjects had an FEV1(%P) of less than 50%.This rela-
tively narrow range of forced expiratory volumes may
have obscured the plausible correlations between the
mean lung density level and impaired lung function.
VA/Q relationships andHRCT
TheVA/Q ratios assessed by MIGETand the single breath
di¡using capacity for carbonmonoxide are sensitive indi-
cators of mild emphysema (6,8). In agreement with pre-
vious studies of patients with stable COPD and
substantial emphysema, theVA/Q relationships in thepre-
sent study were characterised by substantial ventilation
to lung areas with poor perfusion (high VA/Q areas) re-
sulting in an increased V-mean and an increased disper-
sion of ventilation, whereas shunting and perfusion of
low VA/Q areas were scarcely present (2,6,28,39). More-
over, as expected (2,6,28,39), ventilation of poorly per-
fused areas was higher in patients with substantial
emphysema [emph.(E)%P416] than in patients with less
severe emphysema [emph.(E)%Pr16] as shownbyHRCT.
Furthermore, for the entire patient group, no correla-
tions were found between lung function, gas exchange
and VA/Q ratios. In previous studies of COPD patients
with nocturnal or daytime hypoxaemia, signi¢cant
inverse correlation between ventilation of poorly
942 RESPIRATORYMEDICINEperfused lung areas and di¡usion capacity has been
shown (39,40).
There are several possible explanations for the ab-
sence of correlations betweenVA/Q ratios and the extent
of emphysema, di¡using capacity or blood gas levels in
the present study. Firstly, a reduced alveolar surface due
to emphysema is accompanied by an equal reduction in
capillary volume (2,3), preventing the developmentof se-
verely abnormal VA/Q ratios. Secondly, in most COPD
patients an increase in the intra-alveolar pressure occurs
due to in£ammation of the bronchioli and/or due to re-
duced elastic recoil which may decrease the gas £ow
when gas is leaving the alveoli (6,28,35,41).The increased
intra-alveolar pressure compresses the capillaries and
prevents shunting (2,3) and a reduction in the PaO2 level.
When air continues to reach these poorly perfused lung
regions, an increase in highVA/Q areas will be present as
shown in our patients (2,3). Thirdly, as the emphysema-
tous process progresses, the acinar fenestration be-
comes more extensive and the collateral ventilation will
increase (42), preventing a more pronounced VA/Q mis-
match despite a reduced gas exchange surface, re£ected
by a lowDLCO(%P).Thismaybe a possiblemechanism for
the subgroup of our patients with DLCO(%P) of less than
45%, to have a tendency to an increased ventilation to
highVA/Q areas together with augmented di¡using capa-
city (Figs. 4(a) and (b)). Accordingly, it has been shown
that the degree of ventilation towards highVA/Q areas in
emphysematous patients with low pulmonary parenchy-
ma density correlated positively with the level of the dif-
fusing capacity (2). Finally, small airway disease may lead
to an increasing tendency of atelectases and an increase
in the perfusion of poorly ventilated lung areas (28).The
patients in thepresent study had less perfusion of poorly
ventilated lung areas compared with the patients in a
previously investigated COPD patient group su¡ering
fromdaytimehypoxaemia (40).Thepatients presently in-
vestigated, may thus have been su¡ering from less ser-
ious small airway disease than the group of patients
with daytime hypoxaemia (40). These mechanisms may
explain why 80% of our subjects had normal or almost
normal PaO2 (X8.5 kPa) despite that 75% hadmoderate
to severe emphysemameasured by HRCT.
Severe emphysema is associated with increased basal
inspiratorydrive (43) and an increase in energyconsump-
tion of the respiratory muscles even in patients without
daytime hypoxaemia (44).Our patients with severe em-
physema thus maintained relatively normal blood gas le-
vel presumably at the cost of an increased work of
breathing (50% had a BMI below 21kg/m2).
Lung function tests and inert gasmeasurements were
performed in the sitting position, whereas the HRCT
scans were performed in the supine position. However,
the in£uence of the posture was probably small since
the HRCTscans weremeasured at full inspiration and at
full expiration.In conclusion: The extent of emphysema assessed by
HRCT is associatedwith a reduced di¡using capacity for
carbonmonoxide, hyperin£ation and reduced forced ex-
piratory volumes. In COPD patients without severe
blood gas disturbances su¡ering from moderate-to-se-
vere extent emphysema assessed by HRCT images, ele-
vated ventilation of poorly perfused lung areas is found
compared to patients with trivial extent of emphysema.
However, there is no correlationbetween the severity of
extent of emphysema and the VA/Q inequality.Collateral
ventilation and othermechanismsprobably prevent VA/Q
relationships and blood gas levels to deteriorate at the
same pace as the progression of the emphysematous
process.
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